Thailand’s National Center for Genetic Engineering and Biotechnology is expecting two COVID-19 anti-viral nasal sprays to enter human trials by the end of this year.
Deputy government spokeswoman Ratchada Thanadirek said on Wednesday the nasal sprays are based on adenovirus and influenza and testing on mice has provided promising results.
